233 related articles for article (PubMed ID: 34873906)
1. Targeted Inhibition of Tumor Inflammation and Tumor-Platelet Crosstalk by Nanoparticle-Mediated Drug Delivery Mitigates Cancer Metastasis.
Li S; Li L; Lin X; Chen C; Luo C; Huang Y
ACS Nano; 2022 Jan; 16(1):50-67. PubMed ID: 34873906
[TBL] [Abstract][Full Text] [Related]
2. Self-promoted Albumin-Based Nanoparticles for Combination Therapy against Metastatic Breast Cancer via a Hyperthermia-Induced "Platelet Bridge".
Zhao W; Li T; Long Y; Guo R; Sheng Q; Lu Z; Li M; Li J; Zang S; Zhang Z; He Q
ACS Appl Mater Interfaces; 2021 Jun; 13(22):25701-25714. PubMed ID: 34041901
[TBL] [Abstract][Full Text] [Related]
3. Blockade of Platelets Using Tumor-Specific NO-Releasing Nanoparticles Prevents Tumor Metastasis and Reverses Tumor Immunosuppression.
Xu Y; Liu J; Liu Z; Ren H; Yong J; Li W; Wang H; Yang Z; Wang Y; Chen G; Li X
ACS Nano; 2020 Aug; 14(8):9780-9795. PubMed ID: 32806062
[TBL] [Abstract][Full Text] [Related]
4. Self-Delivery Micellar Nanoparticles Prevent Premetastatic Niche Formation by Interfering with the Early Recruitment and Vascular Destruction of Granulocytic Myeloid-Derived Suppressor Cells.
Long Y; Lu Z; Xu S; Li M; Wang X; Zhang Z; He Q
Nano Lett; 2020 Apr; 20(4):2219-2229. PubMed ID: 31823615
[TBL] [Abstract][Full Text] [Related]
5. Metformin and Docosahexaenoic Acid Hybrid Micelles for Premetastatic Niche Modulation and Tumor Metastasis Suppression.
Jiang T; Chen L; Huang Y; Wang J; Xu M; Zhou S; Gu X; Chen Y; Liang K; Pei Y; Song Q; Liu S; Ma F; Lu H; Gao X; Chen J
Nano Lett; 2019 Jun; 19(6):3548-3562. PubMed ID: 31026397
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of platelet function using liposomal nanoparticles blocks tumor metastasis.
Zhang Y; Wei J; Liu S; Wang J; Han X; Qin H; Lang J; Cheng K; Li Y; Qi Y; Anderson GJ; Sukumar S; Li S; Nie G
Theranostics; 2017; 7(5):1062-1071. PubMed ID: 28435448
[TBL] [Abstract][Full Text] [Related]
7. Role of inflammation-associated microenvironment in tumorigenesis and metastasis.
Gao F; Liang B; Reddy ST; Farias-Eisner R; Su X
Curr Cancer Drug Targets; 2014; 14(1):30-45. PubMed ID: 24200082
[TBL] [Abstract][Full Text] [Related]
8. S-Nitrosocaptopril prevents cancer metastasis in vivo by creating the hostile bloodstream microenvironment against circulating tumor cells.
Lu Y; Lian S; Ye Y; Yu T; Liang H; Cheng Y; Xie J; Zhu Y; Xie X; Yu S; Gao Y; Jia L
Pharmacol Res; 2019 Jan; 139():535-549. PubMed ID: 30366102
[TBL] [Abstract][Full Text] [Related]
9. Blocking tumor-platelet crosstalk to prevent tumor metastasis via reprograming glycolysis using biomimetic membrane-hybridized liposomes.
Zhu J; Wang R; Yang C; Shao X; Zhang Y; Hou J; Gao Y; Ou A; Chen M; Huang Y
J Control Release; 2024 Feb; 366():328-341. PubMed ID: 38168561
[TBL] [Abstract][Full Text] [Related]
10. The critical role of platelet in cancer progression and metastasis.
Zhou L; Zhang Z; Tian Y; Li Z; Liu Z; Zhu S
Eur J Med Res; 2023 Sep; 28(1):385. PubMed ID: 37770941
[TBL] [Abstract][Full Text] [Related]
11. Platelet adherence to cancer cells promotes escape from innate immune surveillance in cancer metastasis.
Okazaki M; Yamaguchi T; Tajima H; Fushida S; Ohta T
Int J Oncol; 2020 Oct; 57(4):980-988. PubMed ID: 32945350
[TBL] [Abstract][Full Text] [Related]
12. Platelet P2Y12 is involved in murine pulmonary metastasis.
Wang Y; Sun Y; Li D; Zhang L; Wang K; Zuo Y; Gartner TK; Liu J
PLoS One; 2013; 8(11):e80780. PubMed ID: 24236201
[TBL] [Abstract][Full Text] [Related]
13. The role of tumor-platelet interplay and micro tumor thrombi during hematogenous tumor metastasis.
Shi Q; Ji T; Tang X; Guo W
Cell Oncol (Dordr); 2023 Jun; 46(3):521-532. PubMed ID: 36652166
[TBL] [Abstract][Full Text] [Related]
14. Platelet TLR4-ERK5 Axis Facilitates NET-Mediated Capturing of Circulating Tumor Cells and Distant Metastasis after Surgical Stress.
Ren J; He J; Zhang H; Xia Y; Hu Z; Loughran P; Billiar T; Huang H; Tsung A
Cancer Res; 2021 May; 81(9):2373-2385. PubMed ID: 33687949
[TBL] [Abstract][Full Text] [Related]
15. The tumor microenvironment: An irreplaceable element of tumor budding and epithelial-mesenchymal transition-mediated cancer metastasis.
Li H; Xu F; Li S; Zhong A; Meng X; Lai M
Cell Adh Migr; 2016 Jul; 10(4):434-46. PubMed ID: 26743180
[TBL] [Abstract][Full Text] [Related]
16. Targeting signal transduction pathways of cancer stem cells for therapeutic opportunities of metastasis.
Iqbal W; Alkarim S; AlHejin A; Mukhtar H; Saini KS
Oncotarget; 2016 Nov; 7(46):76337-76353. PubMed ID: 27486983
[TBL] [Abstract][Full Text] [Related]
17. HRG regulates tumor progression, epithelial to mesenchymal transition and metastasis via platelet-induced signaling in the pre-tumorigenic microenvironment.
Cedervall J; Zhang Y; Ringvall M; Thulin A; Moustakas A; Jahnen-Dechent W; Siegbahn A; Olsson AK
Angiogenesis; 2013 Oct; 16(4):889-902. PubMed ID: 23793459
[TBL] [Abstract][Full Text] [Related]
18. Involvement of platelets in tumor cell metastasis.
Tesfamariam B
Pharmacol Ther; 2016 Jan; 157():112-9. PubMed ID: 26615781
[TBL] [Abstract][Full Text] [Related]
19. Fucoidan-functionalized activated platelet-hitchhiking micelles simultaneously track tumor cells and remodel the immunosuppressive microenvironment for efficient metastatic cancer treatment.
Guo R; Deng M; He X; Li M; Li J; He P; Liu H; Li M; Zhang Z; He Q
Acta Pharm Sin B; 2022 Jan; 12(1):467-482. PubMed ID: 35127399
[TBL] [Abstract][Full Text] [Related]
20. Emerging nanomedicine-based therapeutics for hematogenous metastatic cascade inhibition: Interfering with the crosstalk between "seed and soil".
Wu J; Long Y; Li M; He Q
Acta Pharm Sin B; 2021 Aug; 11(8):2286-2305. PubMed ID: 34522588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
